APA (7th ed.) Citation

Fernández Sánchez, M., Višnová, H., Larsson, P., Yding Andersen, C., Filicori, M., Blockeel, C., . . . Mannaerts, B. (2022). A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol. Human reproduction (Oxford), 37(6), 1161-1174. https://doi.org/10.1093/humrep/deac061

Chicago Style (17th ed.) Citation

Fernández Sánchez, Manuel, Hana Višnová, Per Larsson, Claus Yding Andersen, Marco Filicori, Christophe Blockeel, Anja Pinborg, Yacoub Khalaf, and Bernadette Mannaerts. "A Randomized, Controlled, First-in-patient Trial of Choriogonadotropin Beta Added to Follitropin Delta in Women Undergoing Ovarian Stimulation in a Long GnRH Agonist Protocol." Human Reproduction (Oxford) 37, no. 6 (2022): 1161-1174. https://doi.org/10.1093/humrep/deac061.

MLA (9th ed.) Citation

Fernández Sánchez, Manuel, et al. "A Randomized, Controlled, First-in-patient Trial of Choriogonadotropin Beta Added to Follitropin Delta in Women Undergoing Ovarian Stimulation in a Long GnRH Agonist Protocol." Human Reproduction (Oxford), vol. 37, no. 6, 2022, pp. 1161-1174, https://doi.org/10.1093/humrep/deac061.